# DUSP4

## Overview
DUSP4, or dual specificity phosphatase 4, is a gene that encodes a protein belonging to the protein tyrosine phosphatase family, specifically categorized as a dual specificity phosphatase. This protein is involved in the dephosphorylation of both tyrosine and serine/threonine residues, playing a critical role in the regulation of mitogen-activated protein kinases (MAPKs) such as ERK, JNK, and p38. DUSP4 is primarily localized in the nucleus and is integral to various cellular processes, including differentiation, proliferation, and apoptosis, by modulating MAPK signaling pathways (Bermudez2010The; Dougherty2017DualSpecificity). The protein's structure includes a dual specificity phosphatase domain and a rhodanese domain, with several splice variant isoforms that differ in their untranslated regions and domain presence (Varela2020Expression; Patterson2009Dualspecificity). DUSP4's regulatory functions extend to oxidative stress and immune responses, highlighting its importance in maintaining cellular homeostasis and its potential implications in various diseases, including cancer (Dougherty2017DualSpecificity; Lang2019DualSpecificity).

## Structure
DUSP4, also known as dual specificity phosphatase 4, is a protein involved in dephosphorylating both tyrosine and serine/threonine residues. It contains a dual specificity phosphatase domain and a rhodanese domain, which are typical of the protein tyrosine phosphatase family (Patterson2009Dualspecificity). The protein's structure includes motifs such as the kinase-interaction motif (KIM) and a nuclear localization signal (NLS) in variant 1, which are absent in variant 2 (Varela2020Expression). 

DUSP4 has several splice variant isoforms, including variant 1, variant 2, and predicted variant X1. These isoforms differ in their 5'-untranslated regions and the presence of specific domains. Variant 1 initiates translation in exon 1, while variant 2 initiates in exon 3. The C-terminus, containing the catalytic domain, is identical across isoforms, but the N-terminus varies significantly (Varela2020Expression). 

At the quaternary structure level, DUSP4 forms a 24-mer, indicating a complex multimeric structure (Jeong2014The). The protein is also subject to post-translational modifications, such as phosphorylation, which can regulate its stability and activity (Patterson2009Dualspecificity).

## Function
DUSP4, also known as dual-specificity phosphatase 4, is a nuclear phosphatase that plays a crucial role in regulating mitogen-activated protein kinases (MAPKs) such as ERK, JNK, and p38. In healthy human cells, DUSP4 modulates these MAPK signaling pathways, which are essential for various cellular functions including differentiation, proliferation, survival, and apoptosis (Bermudez2010The; Dougherty2017DualSpecificity). By dephosphorylating MAPKs, DUSP4 prevents their overactivation, thereby maintaining proper cell function and preventing excessive cellular responses to stress (Dougherty2017DualSpecificity).

DUSP4 is involved in modulating oxidative stress and nitric oxide (NO) production, particularly in endothelial cells. It upregulates endothelial nitric oxide synthase (eNOS) expression, enhancing NO bioavailability, which is crucial for vascular function and tone (Dougherty2017DualSpecificity). DUSP4 also reduces reactive oxygen species (ROS) generation by downregulating NADPH oxidase 4 (Nox4), thus protecting cells from oxidative damage (Dougherty2017DualSpecificity).

In the immune system, DUSP4 regulates inflammation and immune responses by dephosphorylating ERK and JNK MAPKs, impacting cytokine production and T cell proliferation (Lang2019DualSpecificity). Its activity in these pathways highlights its role in maintaining cellular homeostasis and protecting against stress-induced damage.

## Clinical Significance
DUSP4 (dual specificity phosphatase 4) plays a significant role in various cancers due to its involvement in dephosphorylating MAP kinases, which impacts cell signaling pathways. In colorectal cancer (CRC), high DUSP4 expression is associated with worse overall survival and relapse-free survival in BRAF wild-type patients. It is linked to clinical characteristics typical of BRAF mutant CRC, such as MSI status and tumor site, and is enriched in KRAS G13D mutations, which are associated with a survival benefit after cetuximab treatment (De2013DUSP). Conversely, decreased DUSP4 expression in CRC is associated with advanced tumor characteristics and is an independent risk factor for synchronous distant metastases, suggesting a tumor suppressor role (Saigusa2013Decreased).

In breast cancer, particularly ER-negative and basal-like subtypes, DUSP4 is often underexpressed or deleted, contributing to aggressive cancer phenotypes. Its loss leads to increased MAPK pathway activity, promoting cancer stem cell-like traits and chemotherapy resistance (Mazumdar2016Analysis; Balko2013Activation). In pancreatic cancer, genomic loss of DUSP4 is linked to the progression from pancreatic intraepithelial neoplasms to invasive carcinoma, highlighting its role as an invasion suppressor (Hijiya2016Genomic). These findings underscore the potential of DUSP4 as a biomarker and therapeutic target in various malignancies.


## References


[1. (Mazumdar2016Analysis) Abhijit Mazumdar, Graham M. Poage, Jonathan Shepherd, Anna Tsimelzon, Zachary C. Hartman, Petra Den Hollander, Jamal Hill, Yun Zhang, Jenny Chang, Susan G. Hilsenbeck, Suzanne Fuqua, C. Kent Osborne, Gordon B. Mills, and Powel H. Brown. Analysis of phosphatases in er-negative breast cancers identifies dusp4 as a critical regulator of growth and invasion. Breast Cancer Research and Treatment, 158(3):441–454, July 2016. URL: http://dx.doi.org/10.1007/s10549-016-3892-y, doi:10.1007/s10549-016-3892-y. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10549-016-3892-y)

[2. (Varela2020Expression) Tatiana Varela, Vincent Laizé, Natércia Conceição, Paulo Caldeira, Ana Marreiros, Horácio Guerreiro, and M Leonor Cancela. Expression of dusp4 transcript variants as a potential biomarker for colorectal cancer. Biomarkers in Medicine, 14(8):639–650, June 2020. URL: http://dx.doi.org/10.2217/bmm-2019-0369, doi:10.2217/bmm-2019-0369. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.2217/bmm-2019-0369)

[3. (De2013DUSP) Veerle De Vriendt, Wendy De Roock, Antonio Fabio Di Narzo, Sun Tian, Bart Biesmans, Bart Jacobs, Eva Budinska, Xavier Sagaert, Simona Rossi, Giovanni D’Ario, Mauro Delorenzi, Iris Simon, Loredana Vecchione, and Sabine Tejpar. Dusp 4 expression identifies a subset of colorectal cancer tumors that differ in mapk activation, regardless of the genotype. Biomarkers, 18(6):516–524, July 2013. URL: http://dx.doi.org/10.3109/1354750X.2013.819038, doi:10.3109/1354750x.2013.819038. This article has 29 citations and is from a peer-reviewed journal.](https://doi.org/10.3109/1354750X.2013.819038)

[4. (Bermudez2010The) O. Bermudez, G. Pagès, and C. Gimond. The dual-specificity map kinase phosphatases: critical roles in development and cancer. American Journal of Physiology-Cell Physiology, 299(2):C189–C202, August 2010. URL: http://dx.doi.org/10.1152/ajpcell.00347.2009, doi:10.1152/ajpcell.00347.2009. This article has 173 citations.](https://doi.org/10.1152/ajpcell.00347.2009)

[5. (Balko2013Activation) Justin M. Balko, Luis J. Schwarz, Neil E. Bhola, Richard Kurupi, Phillip Owens, Todd W. Miller, Henry Gómez, Rebecca S. Cook, and Carlos L. Arteaga. Activation of mapk pathways due to dusp4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer. Cancer Research, 73(20):6346–6358, October 2013. URL: http://dx.doi.org/10.1158/0008-5472.can-13-1385, doi:10.1158/0008-5472.can-13-1385. This article has 120 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/0008-5472.can-13-1385)

[6. (Patterson2009Dualspecificity) Kate I. Patterson, Tilman Brummer, Philippa M. O’brien, and Roger J. Daly. Dual-specificity phosphatases: critical regulators with diverse cellular targets. Biochemical Journal, 418(3):475–489, February 2009. URL: http://dx.doi.org/10.1042/bj20082234, doi:10.1042/bj20082234. This article has 576 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj20082234)

[7. (Jeong2014The) Dae Gwin Jeong, Chun Hua Wei, Bonsu Ku, Tae Jin Jeon, Pham Ngoc Chien, Jae Kwan Kim, So Ya Park, Hyun Sook Hwang, Sun Young Ryu, Hwangseo Park, Deok-Soo Kim, Seung Jun Kim, and Seong Eon Ryu. The family-wide structure and function of human dual-specificity protein phosphatases. Acta Crystallographica Section D Biological Crystallography, 70(2):421–435, January 2014. URL: http://dx.doi.org/10.1107/s1399004713029866, doi:10.1107/s1399004713029866. This article has 36 citations.](https://doi.org/10.1107/s1399004713029866)

[8. (Saigusa2013Decreased) Susumu Saigusa, Yasuhiro Inoue, Koji Tanaka, Yuji Toiyama, Yoshinaga Okugawa, Tadanobu Shimura, Junichiro Hiro, Keiichi Uchida, Yasuhiko Mohri, and Masato Kusunoki. Decreased expression of dusp4 is associated with liver and lung metastases in colorectal cancer. Medical Oncology, June 2013. URL: http://dx.doi.org/10.1007/s12032-013-0620-x, doi:10.1007/s12032-013-0620-x. This article has 35 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12032-013-0620-x)

[9. (Hijiya2016Genomic) Naoki Hijiya, Yoshiyuki Tsukamoto, Chisato Nakada, Lam Tung Nguyen, Tomoki Kai, Keiko Matsuura, Kohei Shibata, Masafumi Inomata, Tomohisa Uchida, Akinori Tokunaga, Kohei Amada, Kuniaki Shirao, Yasunari Yamada, Hiromu Mori, Ichiro Takeuchi, Masao Seto, Masahiro Aoki, Mutsuhiro Takekawa, and Masatsugu Moriyama. Genomic loss of dusp4 contributes to the progression of intraepithelial neoplasm of pancreas to invasive carcinoma. Cancer Research, 76(9):2612–2625, May 2016. URL: http://dx.doi.org/10.1158/0008-5472.can-15-1846, doi:10.1158/0008-5472.can-15-1846. This article has 43 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/0008-5472.can-15-1846)

[10. (Dougherty2017DualSpecificity) Julie A. Dougherty, Joanna Kilbane Myers, Mahmood Khan, Mark G. Angelos, and Chun-An Chen. Dual-specificity phosphatase 4 overexpression in cells prevents hypoxia/reoxygenation-induced apoptosis via the upregulation of enos. Frontiers in Cardiovascular Medicine, April 2017. URL: http://dx.doi.org/10.3389/fcvm.2017.00022, doi:10.3389/fcvm.2017.00022. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcvm.2017.00022)

[11. (Lang2019DualSpecificity) Roland Lang and Faizal Raffi. Dual-specificity phosphatases in immunity and infection: an update. International Journal of Molecular Sciences, 20(11):2710, June 2019. URL: http://dx.doi.org/10.3390/ijms20112710, doi:10.3390/ijms20112710. This article has 95 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms20112710)